Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease

被引:22
|
作者
Sarkar, Arighna [1 ]
Mandal, Kalyaneswar [1 ]
机构
[1] Tata Inst Fundamental Res Hyderabad, TIFR Ctr Interdisciplinary Sci, 36-P Gopanpally, Hyderabad 500046, Telangana, India
关键词
allosteric inhibitors; antiviral drugs; drug screening; SARS-CoV-2; X-ray crystallographic screening;
D O I
10.1002/anie.202107481
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
[No abstract available]
引用
收藏
页码:23492 / 23494
页数:3
相关论文
共 50 条
  • [31] An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease
    Djokovic, Nemanja
    Ruzic, Dusan
    Djikic, Teodora
    Cvijic, Sandra
    Ignjatovic, Jelisaveta
    Ibric, Svetlana
    Baralic, Katarina
    Buha Djordjevic, Aleksandra
    Curcic, Marijana
    Djukic-Cosic, Danijela
    Nikolic, Katarina
    MOLECULAR INFORMATICS, 2021, 40 (05)
  • [32] Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach
    Ambrosio, Francesca Alessandra
    Costa, Giosue
    Romeo, Isabella
    Esposito, Francesca
    Alkhatib, Mohammad
    Salpini, Romina
    Svicher, Valentina
    Corona, Angela
    Malune, Paolo
    Tramontano, Enzo
    Ceccherini-Silberstein, Francesca
    Alcaro, Stefano
    Artese, Anna
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (11) : 3601 - 3613
  • [33] A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors
    Jo, Seri
    Signorile, Luca
    Kim, Suwon
    Kim, Mi-Sun
    Huertas, Oscar
    Insa, Raul
    Reig, Nuria
    Shin, Dong Hae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [34] Drug development targeting SARS-CoV-2 main protease
    Bulut, Haydar
    GLOBAL HEALTH & MEDICINE, 2022, 4 (06): : 296 - 300
  • [35] Repurposing SARS-CoV-2 Main Protease Inhibitors for HIV-1 Protease Inhibition
    Minkkinen, Jacob P.
    Gentile, Lisa
    FASEB JOURNAL, 2022, 36
  • [36] A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
    Islam, Rajib
    Parves, Md Rimon
    Paul, Archi Sundar
    Uddin, Nizam
    Rahman, Md Sajjadur
    Al Mamun, Abdulla
    Hossain, Md Nayeem
    Ali, Md Ackas
    Halim, Mohammad A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (09): : 3213 - 3224
  • [37] Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
    Dai, Wenhao
    Zhang, Bing
    Jiang, Xia-Ming
    Su, Haixia
    Li, Jian
    Zhao, Yao
    Xie, Xiong
    Jin, Zhenming
    Peng, Jingjing
    Liu, Fengjiang
    Li, Chunpu
    Li, You
    Bai, Fang
    Wang, Haofeng
    Cheng, Xi
    Cen, Xiaobo
    Hu, Shulei
    Yang, Xiuna
    Wang, Jiang
    Liu, Xiang
    Xiao, Gengfu
    Jiang, Hualiang
    Rao, Zihe
    Zhang, Lei-Ke
    Xu, Yechun
    Yang, Haitao
    Liu, Hong
    SCIENCE, 2020, 368 (6497) : 1331 - +
  • [38] Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
    Aherfi, Sarah
    Pradines, Bruno
    Devaux, Christian
    Honore, Stephane
    Colson, Philippe
    La Scola, Bernard
    Raoult, Didier
    FUTURE MICROBIOLOGY, 2021, 16 (17) : 1341 - 1370
  • [39] Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
    Mahmud, Shafi
    Paul, Gobindo Kumar
    Biswas, Suvro
    Afrose, Shamima
    Mita, Mohasana Akter
    Hasan, Md. Robiul
    Shimu, Mst. Sharmin Sultana
    Hossain, Alomgir
    Promi, Maria Meha
    Ema, Fahmida Khan
    Chidambaram, Kumarappan
    Chandrasekaran, Balakumar
    Alqahtani, Ali M.
    Bin Emran, Talha
    Abu Saleh, Md.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [40] A Drug Repurposing Approach to Identify Therapeutics by Screening Pathogen Box Exploiting SARS-CoV-2 Main Protease
    Tyagi, Rashmi
    Paul, Anubrat
    Raj, V. Samuel
    Ojha, Krishna Kumar
    Kumar, Sunil
    Panda, Aditya K.
    Chaurasia, Anurag
    Yadav, Manoj Kumar
    CHEMISTRY & BIODIVERSITY, 2023, 20 (02)